Jan 7, 2022· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2021-D-1031-0023
Please see attached comments from Consumer Healthcare Products Association
FDANonrulemakingFDA-2021-D-1031
Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act; Draft Guidance for Industry; Availability
RIN
—
Last modified
Feb 6, 2024
Comment window
closed 1667d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Jan 7, 2022 and Jan 7, 2022. 3 other organizations filed here. The comment window closed 1667d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (3)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%
- Animal Health Institutetrade assoc.2 filings · confidence 97%
- Association for Accessible Medicinestrade assoc.2 filings · confidence 97%
- Parenteral Drug Associationtrade assoc.1 filing · confidence 97%